Cargando…
Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease
BACKGROUND: The complex pathophysiology of Alzheimer’s disease (AD) hampers the development of effective treatments. Attempts to prevent neurodegeneration in AD have failed so far, highlighting the need for further clarification of the underlying cellular and molecular mechanisms. Neuroinflammation...
Autores principales: | Ruiz-Pérez, Gonzalo, Ruiz de Martín Esteban, Samuel, Marqués, Sharai, Aparicio, Noelia, Grande, M. Teresa, Benito-Cuesta, Irene, Martínez-Relimpio, Ana M., Arnanz, M. Andrea, Tolón, Rosa M., Posada-Ayala, María, Cravatt, Benjamin F., Esteban, José A., Romero, Julián, Palenzuela, Rocío |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482614/ https://www.ncbi.nlm.nih.gov/pubmed/34587978 http://dx.doi.org/10.1186/s12974-021-02276-y |
Ejemplares similares
-
Cannabinoid CB(2) Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease
por: Ruiz de Martín Esteban, Samuel, et al.
Publicado: (2022) -
Phagocytosis in Teleosts. Implications of the New Cells Involved
por: Esteban, María Ángeles, et al.
Publicado: (2015) -
FAAH selectively influences placebo effects
por: Peciña, M., et al.
Publicado: (2013) -
Cannabinoid CB(2) receptors in the mouse brain: relevance for Alzheimer’s disease
por: López, Alicia, et al.
Publicado: (2018) -
FAAH genetic variation enhances fronto-amygdala function in mouse and human
por: Dincheva, Iva, et al.
Publicado: (2015)